Home
World Journal of Biological and Pharmaceutical Research
Peer-Reviewed • ISSN: 2799-0338 • Impact Factor 7.8

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

🌟 🧬 World Journal of Biological and Pharmaceutical Research (WJBPR) 🧬 🌟

Low-Cost Journal Publication | CrossRef DOI | Transparent Peer Review Process

International, Open Access, Peer-Reviewed, Multidisciplinary Journal in Biological and Pharmaceutical Sciences, Indexed in Major Databases, DOI Assignment (Crossref)

ISSN: 2799-0338 | Impact Factor: 7.8 | ESTD Year: 2021 | Charges 35 USD

Published paper PDF, E-certificate of publication, Official letter of acceptance, Peer review report, Cover page, Editorial information, and Indexing details.

📄 Submit Paper 👉 Author Guidelines

Successful treatment of type II diabetes mellitus with infected diabetic foot ulcer caused by ESBL producing Klebsiella pneumonia with cefepime plus sulbactam (Supime): A case report

Breadcrumb

  • Home
  • Successful treatment of type II diabetes mellitus with infected diabetic foot ulcer caused by ESBL producing Klebsiella pneumonia with cefepime plus sulbactam (Supime): A case report

Vijay Shankar Upadhyay 1, * and Ayush Upadhayay 2

1 General Medicine, Ashadeep Hospital & Heart Care, Research Center, Jaunpur, Utter Pradesh, India.
2 PMCH Udaipur, Utter Pradesh, India.
 

Review Article
World Journal of Biological and Pharmaceutical Research, 2022, 02(02), 058–062.
Article DOI: 10.53346/wjbpr.2022.2.2.0024
DOI url: https://doi.org/10.53346/wjbpr.2022.2.2.0024

Received on 02 March 2022; revised on 04 April 2022; accepted on 06 April 2022
 

Diabetic patients are at significant risk of developing neuropathy, leading to a diabetic foot injury. Complications of diabetic foot injury may lead to gangrene and non-traumatic lower extremity amputations. Diabetic patients with diabetic foot ulcers are more prone to bacterial infections and are associated with high chances of amputation. The diabetic patient flora provides an ideal environment for Gram-positive and Gram-negative bacterial growth, leading to increased morbidity and mortality. The antimicrobial-resistant Gram-negative bacterial infections in diabetic patients have a higher probability of amputation. Here we discuss a case of a 70-year male diabetic patient successfully treated with Supime (cefepime plus sulbactam) who had undergone an amputation of the right great toe and infected left foot ulcer due to ESBL producing K. Pneumonia.
 

Diabetic Foot; ESBL; K Pneumonia; Supime; Cefepime plus sulbactam

https://wjbpr.zealjournals.com/sites/default/files/fulltext_pdf/WJBPR-2022-0024…

Preview Article PDF

Vijay Shankar Upadhyay and Ayush Upadhayay. Successful treatment of type II diabetes mellitus with infected diabetic foot ulcer caused by ESBL producing Klebsiella pneumonia with cefepime plus sulbactam (Supime): A case report. World Journal of Biological and Pharmaceutical Research, 2022, 02(02), 058–062. Article DOI: https://doi.org/10.53346/wjbpr.2022.2.2.0024

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Biological and Pharmaceutical Research - All rights reserved

Developed & Designed by VS Infosolution